DE60221402D1 - Mittel zur prävention und behandlung des vorwiegend durch obstipation geprägten reizdarms - Google Patents

Mittel zur prävention und behandlung des vorwiegend durch obstipation geprägten reizdarms

Info

Publication number
DE60221402D1
DE60221402D1 DE60221402T DE60221402T DE60221402D1 DE 60221402 D1 DE60221402 D1 DE 60221402D1 DE 60221402 T DE60221402 T DE 60221402T DE 60221402 T DE60221402 T DE 60221402T DE 60221402 D1 DE60221402 D1 DE 60221402D1
Authority
DE
Germany
Prior art keywords
group
obstipation
presently
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60221402T
Other languages
English (en)
Other versions
DE60221402T2 (de
Inventor
S Yamazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Publication of DE60221402D1 publication Critical patent/DE60221402D1/de
Application granted granted Critical
Publication of DE60221402T2 publication Critical patent/DE60221402T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyridine Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE60221402T 2001-08-24 2002-03-14 Mittel zur prävention und behandlung des vorwiegend durch obstipation geprägten reizdarms Expired - Lifetime DE60221402T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001254662 2001-08-24
JP2001254662 2001-08-24
PCT/JP2002/002402 WO2003018012A1 (fr) 2001-08-24 2002-03-14 Agent pour la prevention/le traitement du syndrome du colon irritable (sci) avec predominance de constipation

Publications (2)

Publication Number Publication Date
DE60221402D1 true DE60221402D1 (de) 2007-09-06
DE60221402T2 DE60221402T2 (de) 2008-04-03

Family

ID=19082790

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60221402T Expired - Lifetime DE60221402T2 (de) 2001-08-24 2002-03-14 Mittel zur prävention und behandlung des vorwiegend durch obstipation geprägten reizdarms
DE60231017T Expired - Fee Related DE60231017D1 (de) 2001-08-24 2002-03-14 Mittel zur Prävention und Behandlung des vorwiegend durch Obstipation geprägten Reizdarms

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60231017T Expired - Fee Related DE60231017D1 (de) 2001-08-24 2002-03-14 Mittel zur Prävention und Behandlung des vorwiegend durch Obstipation geprägten Reizdarms

Country Status (13)

Country Link
US (2) US20040248927A1 (de)
EP (2) EP1419772B1 (de)
JP (1) JPWO2003018012A1 (de)
KR (1) KR100869759B1 (de)
CN (1) CN1545412A (de)
AT (2) ATE367813T1 (de)
CA (1) CA2457053C (de)
CY (1) CY1106913T1 (de)
DE (2) DE60221402T2 (de)
DK (1) DK1419772T3 (de)
ES (1) ES2289086T3 (de)
PT (1) PT1419772E (de)
WO (1) WO2003018012A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060118421A (ko) * 2003-08-29 2006-11-23 다이노젠 파마세우티컬스, 인코포레이티드 위장 운동 장애의 치료에 유용한 조성물
SE0401578D0 (sv) 2004-06-18 2004-06-18 Active Biotech Ab Novel compounds
WO2008100422A1 (en) * 2007-02-12 2008-08-21 Dynogen Pharmaceuticals, Inc. Compositions comprising mkc-733 (pumosetrag) useful for treating irritable bowel syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
JP3250921B2 (ja) * 1994-11-21 2002-01-28 三菱化学株式会社 腸管運動機能不全性疾患の治療剤
JPH08286450A (ja) 1995-04-19 1996-11-01 Matsushita Electric Ind Co Ltd 画像読取り等複合装置
JP2003514853A (ja) * 1999-11-23 2003-04-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 底を弛緩させるための５ｈｔ３アゴニストの使用
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease

Also Published As

Publication number Publication date
ATE367813T1 (de) 2007-08-15
CN1545412A (zh) 2004-11-10
KR20040047774A (ko) 2004-06-05
WO2003018012A1 (fr) 2003-03-06
EP1419772A1 (de) 2004-05-19
ES2289086T3 (es) 2008-02-01
CY1106913T1 (el) 2012-09-26
PT1419772E (pt) 2007-09-05
EP1829543B1 (de) 2009-01-21
DE60221402T2 (de) 2008-04-03
DK1419772T3 (da) 2007-11-12
ATE421323T1 (de) 2009-02-15
DE60231017D1 (de) 2009-03-12
EP1419772B1 (de) 2007-07-25
JPWO2003018012A1 (ja) 2004-12-09
CA2457053A1 (en) 2003-03-06
EP1829543A1 (de) 2007-09-05
EP1419772A4 (de) 2004-11-24
US20070004770A1 (en) 2007-01-04
KR100869759B1 (ko) 2008-11-21
CA2457053C (en) 2010-10-26
US7897614B2 (en) 2011-03-01
US20040248927A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
MY130755A (en) Colchinol derivatives as vascular damaging agents
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
HUP0401849A2 (hu) Kinuklidinszármazékok, ezeket tartalmazó gyógyászati készítmények, továbbá ezek alkalmazása M2 és/vagy M3 muszkarin receptor inhibitorként
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ATE370138T1 (de) Neue imidazopyridine und ihre verwendung
BR0309345A (pt) Composto ou sais farmaceuticamente aceitáveis do mesmo, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou de distúrbios de dano intelectual, e de jetlag, interrupção do hábito de fumar, dependência de nicotina, ânsias, dor e colite ulcerativa
WO2005011656A3 (en) Pyridyl derivatives and their use as therapeutic agents
WO2005011654A3 (en) Pyridyl derivatives and their use as therapeutic agents
SG146694A1 (en) 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo-2,3-c pyridin-2- ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes
GR3036954T3 (en) Quinazoline derivatives
DE602004007239D1 (de) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN
CY2466B1 (en) Phenyl dihydrobenzofuranes.
NZ503294A (en) Halogen substituted tetracyclic tetrahydrofuran derivatives and pharmaceutical use
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
ATE402707T1 (de) Imidazoä1,5aütriazoloä1,5dübenzodiazepin- derivative zur behandlung kognitiver störungen
WO2000068198A3 (en) Heterosubstituted pyridine derivatives as pde 4 inhibitors
DE59610031D1 (de) Cyclohexyldihydrobenzofurane
EP1228758A4 (de) Prohylaktische und therapeutische mittel für entzündliche darmerkrankungen
DE60221402D1 (de) Mittel zur prävention und behandlung des vorwiegend durch obstipation geprägten reizdarms
TWI256314B (en) Preventive-therapeutical medicament for gastroesophageal reflux disease
JP2003518500A (ja) 痛みの処置のための方法および組成物
AU779703B2 (en) Compound and method for the treatment of pain
HUP0300043A2 (en) Method and composition for the treatment of pain
UA91330C2 (ru) ПРОИЗВОДНЫЕ 1,1,1-ТРИФТОР-4-ФЕНИЛ-4-МЕТИЛ-2-(1Н-ПИРРОЛО[2,3-с]ПИРИДИН-2-ИЛМЕТИЛ)ПЕНТАН-2-ОЛА И РОДСТВЕННЫЕ СОЕДИНЕНИЯ КАК ГЛЮКОКОРТИКОИДНЫЕ ЛИГАНДЫ ДЛЯ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ И ДИАБЕТА
WO2004050019A3 (en) Method and compositions for treating anxiety

Legal Events

Date Code Title Description
8364 No opposition during term of opposition